Program Activities

Challenges of Advancing Early Stage Drug Discovery and  the Office of Therapeutics Alliances

  • Synergize with intellectual property and licensing teams on project activities to facilitate efficient project management, improve patent filing and increase licensing activity
  • Develop new partnerships with biopharma companies and investors for on-going projects
  • Increase value and commercial potential of intellectual property by de-risking investment through OTA-sponsored development and shared development with partners
  • Develop translational working groups focused on specific disease targets and their therapeutic potential